Scientists discover in studies with mice that an anti-cancer gene also fights obesity
Researchers from the Spanish National Cancer Research Centre working with mice have revealed that one of the main genes protecting against cancer brings two additional health benefits by boosting longevity and combating obesity. ...
Cancer
Mar 06, 2012 |
5 / 5 (2) |
0
New point of attack for breast cancer with poor prognosis
(Medical Xpress) -- Scientists from the Friedrich Miescher Institute for Biomedical Research describe how the protein phosphatase SHP2 promotes breast cancer with poor prognosis. As they report in the latest ...
Cancer
Mar 05, 2012 |
5 / 5 (2) |
0
|
Potential new therapeutic target for a subset of aggressive breast cancers
Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim have now discovered that they can prevent the formation of metastases by blocking the receptor protein Plexin B1.
Cancer
Mar 01, 2012 |
5 / 5 (1) |
0
Targeted drug helps leukemia patients who do not benefit from initial therapy
A new study has found that patients with chronic myeloid leukemia (CML) who have not responded to interferon treatments experience long-term benefits when they switch to the targeted drug imatinib. Published early online ...
Cancer
Feb 27, 2012 |
5 / 5 (1) |
0
Blocking telomerase kills cancer cells but provokes resistance, progression
Inhibiting telomerase, an enzyme that rescues malignant cells from destruction by extending the protective caps on the ends of chromosomes, kills tumor cells but also triggers resistance pathways that allow cancer to survive ...
Cancer
Feb 21, 2012 |
5 / 5 (2) |
0
|
'First-in-human' drug for malignant glioma available in experimental trial
The UC Cancer Institute is one of three centers internationally approved to test an experimental drug's safety and pharmacokinetics and also assess the clinical benefit against recurrent malignant glioma, an aggressive form ...
Cancer
Feb 15, 2012 |
5 / 5 (2) |
0
Role of known cancer gene in ovarian cancer investigated
The role of a known cancer-causing gene in the development of the most lethal type of ovarian cancer is being investigated by researchers from the Walter and Eliza Hall Institute after they were awarded a Cure Cancer Australia ...
Cancer
Feb 14, 2012 |
5 / 5 (1) |
0
Therapy targets leukemia stem cells
New research takes aim at stubborn cancer stem cells that are thought to be responsible for treatment resistance and relapse. The study, published by Cell Press in the February 14 issue of the journal Cancer Cell, provid ...
Cancer
Feb 13, 2012 |
4 / 5 (4) |
0
Molecular profiling reveals differences between primary and recurrent ovarian cancers
There is a need to analyze tumor specimens at the time of ovarian cancer recurrence, according to a new study published in Molecular Cancer Therapeutics. Researchers used a diagnostic technology called molecular profiling to examine ...
Cancer
Feb 10, 2012 |
not rated yet |
0
|
Imaging live mouse spinal cord will aid trauma therapy
(Medical Xpress) -- To study spinal cord injuries, researchers have had to conduct exploratory surgeries on mice to determine how nerves and other cells respond after trauma. But these approaches have only ...
Medical research
Jan 25, 2012 |
5 / 5 (1) |
0
|
Possible new pathway can overcome glioblastoma resistance
Glioblastoma, a lethal brain cancer, is one of the most resistant to available therapies and patients typically live approximately 15 months.
Cancer
Jan 24, 2012 |
5 / 5 (1) |
0
Three is the magic number: A chain reaction required to prevent tumor formation
Protein p53 is known for controlling the life and death of a cell and has a key role in cancer research. P53 is known to be inactive in 50 percent of cancer patients. If researchers succeed in re-establishing the presence ...
Cancer
Jan 20, 2012 |
5 / 5 (1) |
0
Cell senescence does not stop tumor growth
Since cancer cells grow indefinitely, it is commonly believed that senescence could act as a barrier against tumor growth and potentially be used as a way to treat cancer. A collaboration between a cancer biologist from the ...
Cancer
Jan 19, 2012 |
5 / 5 (2) |
0
Researchers find new, noninvasive way to identify lymph node metastasis
Using two cell surface markers found to be highly expressed in breast cancer lymph node metastases, researchers at Moffitt Cancer Center, working with colleagues at other institutions, have developed targeted, fluorescent ...
Cancer
Jan 12, 2012 |
not rated yet |
0
Unexpected discovery opens up new opportunities for targeting cancer
Scientists at the University of Leicester have opened up a whole new approach to the therapeutic intervention for a family of anti-cancer drug targets, thanks to a completely new and unexpected finding.
Cancer
Jan 10, 2012 |
not rated yet |
0
|
